Darren Bianchi

We are developing an entirely novel class of orally available small molecules to address untreatable cancers. Our first drug, Ag5, aims to redefine the treatment landscape for solid tumours on both sides of the blood brain barrier by targeting the 30% of all cancers that generate high levels of Reactive Oxygen Species. This large group contains cancers driven by mutations in the KRAS gene, triple negative breast cancer and glioblastoma-all of which are urgent unmet medical needs with large potential markets. We have a deep pipeline of follow on medicines. Our goal is to revolutionise cancer treatment for patients and their doctors.

We are developing an entirely novel class of orally available small molecules to address untreatable cancers. Our first drug, Ag5, aims to redefine the treatment landscape for solid tumours on both sides of the blood brain barrier by targeting the 30% of all cancers that generate high levels of Reactive Oxygen Species. This large group contains cancers driven by mutations in the KRAS gene, triple negative breast cancer and glioblastoma-all of which are urgent unmet medical needs with large potential markets. We have a deep pipeline of follow on medicines. Our goal is to revolutionise cancer treatment for patients and their doctors.

NANOGAP develops and manufactures novel nanomaterials for use in diverse markets and applications including: • Conductive: High performance silver nanowires and silver nanoparticles for printed electronics • Luminescent: Unique, customizable high Stokes shift nanomaterials for security printing • Antimicrobial: Silver Atomic Quantum Clusters are non-toxic and provide long-lasting performance at low concentrations in clear, colorless antimicrobial coatings • Catalytic: Atomic Quantum Clusters with strong catalytic activity due to quantum effects for a range of homogeneous and heterogeneous applications • Therapeutic: Atomic Quantum Clusters as topoisomerase inhibitors for cancer treatment Materials can be tailored to our customers’ exacting requirements including particle size, morphology, surface functionalization, and carrier fluid.

Brilliant Group offers a world-class range of high-quality daylight fluorescent pigments, colorants, dispersions, and paint and ink concentrates to the global marketplace. Coupled with our focus on total customer satisfaction, we bring a comprehensive solution to your fluorescent color needs. brilliant® was founded by individuals with a high level of experience in, and extensive knowledge of, the fluorescent color business. Our aim is to offer ‘best of breed’ fluorescent technology, provide readily available local inventory and technical support, all the while bringing exceptional value. We apply our extensive technical experience and market knowledge to develop products that meet the ever-changing needs of our customers. We then apply the latest industry standards to our quality control methods so that our customers get what they expect, every time. Our company headquarters and US manufacturing site is located in the San Francisco Bay Area of Northern California. It is here that we manufacture various products, perform all of our laboratory testing, conduct product development, and maintain inventory for the US market. We are further supported by our network of worldwide distribution partners so as to be able to provide local service in numerous markets around the globe. In the world of fluorescent pigments, it’s important to know that there is a real alternative. It’s one where knowledgeable people provide local service and technical support. Now, that’s brilliant®!